T1	Participants 29 73	patients with and without polycystic ovaries
T2	Participants 193 277	76 patients with polycystic ovaries (PCO) diagnosed on pre-treatment ultrasound scan
T3	Participants 406 472	receiving significantly less human menopausal gonadotrophin (HMG),
T4	Participants 1355 1399	Patients with and without PCO undergoing IVF
